Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
The Pharma Data
JANUARY 12, 2021
“Tackling the COVID-19 pandemic will require a combination of public health measures, vaccines and therapeutics. To date, nearly 15,000 people have participated in casirivimab and imdevimab clinical trials. To date, nearly 15,000 people have participated in casirivimab and imdevimab clinical trials. Schleifer , M.D.,
Let's personalize your content